Researchers from the University of Michigan conducted a study that suggests that by using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week. Access to this data would allow clinicians to adapt cancer treatments to patients on an individual level.
